Wednesday, January 27, 2016

Cherubim Interests (CHIT) Diversifying its Business with Texas Real Estate and the Cannabis Industry

Being multifaceted and easily adaptable to a constantly changing business dynamic in the U.S. is essential for companies to stand the test of time. A diversified company that is taking advantage of the opportunities present in multiple industries with its business model is Cherubim Interests, Inc. (OTC: CHIT). The company targets alternative, commercial, single and multifamily dwellings for the purpose of investment purchase. Also, through its BudCube Cultivation Systems USA subsidiary, Cherubim Interests has developed a proprietary controlled environment cultivation technology aimed at helping cultivators of legal medical and recreational cannabis, as well as other plant species, meet rising market demand.

Coupled with the real estate development and property management business model of parent company Cherubim Interests, BudCube is able to offer prospective cultivators quick entry into the rapidly expanding cannabis cultivation market at a price point that is extremely attractive when compared to traditional construction solutions.

Legal marijuana is the fastest-growing industry in the U.S., and if the trend toward legalization spreads to all 50 states, marijuana could become larger than the organic food industry, according to a report obtained by The Huffington Post. Researchers from The ArcView Group, a cannabis industry investment and research firm based in Oakland, California, found that the U.S. market for legal cannabis grew 74 percent in 2014 to $2.7 billion, up from $1.5 billion in 2013, and it is projected to be $37 billion after full legalization.

BudCube’s business model is unparalleled in the cultivation industry. Cherubim Interests will own and develop each property, while BudCube will construct, deploy and lease turnkey cultivation systems to tenants. The company plans to offer both single tenant ‘macro’ solutions and multi-tenant ‘micro’ solutions to meet the unique needs of both established and upstart cultivation operations.

Also, Cherubim Interests recently announced its acquisition of Golden Eagle Roofing, LLC. This acquisition allows the company to immediately engage in the roofing and insurance restoration businesses in Rowlett and Garland, Texas, and the surrounding areas, where an EF-4 tornado destroyed and damaged more than 450 buildings in 2015.

For more information, visit www.cherubiminterests.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

Lingo Media Corporation (LMDCF) (LM:CA) to Present at the World Outlook Financial Conference 2016 in Vancouver

Earlier this week, Lingo Media Corporation (OTCQB: LMDCF) (TSX-V: LM), an EdTech company using innovative online and print-based technologies and solutions to change the way the world learns English, announced that it will be presenting at the upcoming World Outlook Financial Conference 2016, which will be held January 29-30 at the Westin Bayshore Hotel in Vancouver. The company will also host a booth at the conference in order to provide attendees with an opportunity to meet and speak with the Lingo management team.

The World Outlook Financial Conference is sponsored by MoneyTalks, a popular radio show hosted by Michael Campbell. For over three decades, MoneyTalks has been offering unique and valuable insight to Canadian investors, and the show currently boasts more than half a million weekly listeners. The conference is expected to be attended by hundreds of pre-qualified, high net worth investors and active market participants looking to meet with exhibitors. Lingo will have an additional opportunity to reach these investors as one of four top-performing companies invited to make presentations at the conference’s VIP Small-Cap Luncheon.

In recent quarters, Lingo has recorded strong financial growth on the back of an aggressive expansion campaign throughout Latin America. During the quarter ended September 30, 2015, the company achieved its fourth consecutive profitable quarter, along with a 441 percent year-over-year increase in total revenue. This growth is particularly noteworthy, because it was derived primarily from Lingo’s rapidly expanding digital-learning software division. The company’s legacy textbook publishing income, which stems from exclusive agreements with key government and industry partners in China’s expansive education market, is recorded seasonally, in Q2 and Q4, as royalty revenues.

Moving forward, Lingo plans to build on its recent progress by expanding its presence throughout Latin America while actively pursuing opportunities in other regions around the globe. This strategy is expected to play a key role in the company’s efforts to continue promoting sustainable returns in the months to come.

“While Latin America remains our initial market focus, demand is emerging from other regions,” Michael Kraft, president and chief executive officer of Lingo, stated in a news release. “The company is pursuing strategic partnerships for global distribution as part of its plan as the EdTech market for English language learning continues to grow worldwide.”

For more information on the company, visit www.lingomedia.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

The Bowser Report – Daily Mover Alert January 26

Wednesday, The Bowser Report issued a daily mover alert on Where Food Comes From (WFCF), which gained more than 10% for the day.

WFCF has been on a downtrend lately, as earnings have remained inconsistent despite continued revenue growth. Today’s move is a bounce after WFCF dropped $0.20 per share yesterday.

Avoid WFCF unless you already have a position, although you may keep it on your watch list. WFCF has a Bowser Rating of 7, pitting it in Category 3 and making it “un-buyable” (must be 8 or higher to consider buyable using the Bowser Game Plan).

Those with shares of WFCF continue following the Game Plan. Earnings are expected in the third week of February.

To learn more about The Bowser Report, visit https://thebowserreport.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net


Track the Latest Stock Picks Every Day via The QualityStocks Daily

With all of the stock picks and recommendations available today, selecting and deciding on the right stocks can be tedious and time consuming. At QualityStocks, we collate hundreds of investment newsletters into The ONE and ONLY “The QualityStocks Daily”, featuring a summary format in which you can view the latest stock picks.

Our newsletter provides the latest coverage in the Small-Cap and Micro-Cap markets, providing you with a ONE-STOP information resource. The QualityStocks Daily helps subscribers stay on top of momentum trading opportunities, discover high performance winning stock picks, track the performance of hundreds of stock newsletters and learn about new investment newsletter sources as they are published!

To sign up for the QualityStocks Newsletter, visit www.Signup.QualityStocks.net

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.


Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

Tuesday, January 26, 2016

Forward Industries, Inc. (FORD) Settled Proxy Battle, Return to Profitability, Bayer Supply Extension are Positive Indicators Moving Forward

While just about every investor has likely heard of globally-recognized companies and brands such as Lenovo’s Motorola Mobility (OTC: LNVGY), Nokia (NYSE: NOK), Philips (NYSE: PHG) and Toshiba (OTC: TOSYY), or healthcare sector operators like Roche (OTCQX: RHHBY) and Johnson & Johnson (NYSE: JNJ), many remain surprisingly unfamiliar with the increasingly vital carrying case and protective solutions provider which reinforces these heavy-hitters: Forward Industries (NASDAQ: FORD). West Palm Beach, Florida-headquartered Forward Industries conceptualizes, designs and delivers an extremely wide variety of tailored carrying case and usability solutions for gadgets produced by these globally-recognized brands. These solutions are either packaged with the branded product or sold in the retail aftermarket, and they significantly enhance the functionality, as well as brand presence, of the core product.

Whether we are talking about a carrying case for portable electronic healthcare devices, such as the blood glucose monitoring kits used by diabetics, handheld bar code scanners used in a warehouse, GPS devices for recreation and navigation, firearms, or even the average consumer’s smartphone/tablet – chances are that Forward Industries makes a carrying case, clip, stand or other accessory that the reader has used. With a highly skilled team of innovators that work hand-in-hand with the company’s OEM clients (or their contract manufacturing firms) to custom design the perfect carry, protective or usability accessory and over three decades of experience leveraging the premium manufacturing metrics available in China and the Far East, Forward Industries is one of the most sought-after accoutrement design shops on earth today.

After Forward Industries has worked with the OEM customer and its sizable supply chain in Asia, consisting of 800,000 square feet of manufacturing capacity, the company then ensures that gold-standard quality control procedures are utilized in order to make certain that the commercially approved production units meet with the exacting specifications that have been laid out. The company’s logistical and global warehousing capacity, as well as its comprehensive compliance structures, have won Forward Industries mounting favor among the roughly 81 OEMs around the world with which the company currently does business.

One of the largest companies that FORD has such a tight-knit relationship with is Germany-based multinational chemical and pharmaceutical developer, Bayer (OTC: BAYRY), with whom Forward Industries recently signed a sizable carry case extension deal. This extension deal adds to a relationship stretching back several years and has FORD supplying the customized carrying cases that go with Bayer’s diabetic products all the way through to the end of 2018. Such a deal speaks volumes about how Forward Industries has become one of only a handful of trusted go-to suppliers chosen by healthcare and tech sector majors to handle the accessories for their most important products.

The Bayer extension deal should also give investors a hint as to how important the company’s proven abilities to satisfy the complex compliance demands within this heavily regulated industry are, especially when it comes to differentiating FORD from its numerous competitors. Little wonder then that the company’s Q4 financials (ended September 30, 2015) showed a 2.3 percent increase in gross profit percentages when compared to Q4 FY14, or the company’s 128 percent jump in gross profits over the same interval. FORD’s Q4 FY15 EPS of $0.03 per share was quite a feat considering the turbulence experienced by the company due to an expensive (now resolved) proxy battle and paints a stark contrast with the loss of $(0.08) per share seen during the same quarter in the prior year.

The company’s ability to turn profitability around so sharply despite the proxy battle, and its ability to shore up its OEM-focused presence with the Bayer deal, is a positive signal to markets about where the company’s CEO, Terry Wise, is taking Forward Industries this year. Consistently delighted multinational customers, who continue to praise FORD for its quality and cost-effectiveness, will most likely see this case and accessory designer through to a profitable 2016 – following up nicely on its return to the black, with two back-to-back quarters of solid profitability.

Forward Industries is now fully committed to mustering sustained momentum via the hammering out of long-term sourcing agreements with new and existing customers, as well as a broadening of its product mix, which should help FORD secure access to an expanding customer base. Innovation has long been the watchword at FORD, and its in-house conceptualization and design capabilities are a force in this sector that has to be reckoned with. Given that the company has the ability to go from co-creation sessions with the customer, through traditional art approaches and on into 3D modelling quite rapidly, rounding out the design phase with both traditional mockup and 3D printing, FORD should be able to continue landing new customers across the board with ease this year.

Already serving industries ranging from tech, medical devices and video gaming to military, government and automotive, the sky is the limit for Forward Industries when it comes to design. With warehousing and production in Shenzhen and Dongguan, China, as well as operational footholds in Tsim Sha Tsui, Hong Kong and Taipei, Taiwan, Forward Industries can offer unique scaling/sourcing benefits to its customers, and also has the global sales footprint to back it up. With sales offices in California and Indiana, as well as Switzerland – managed via the company’s wholly-owned Forward US and Forward Switzerland subsidiaries – FORD has the cost-effective manufacturing/supply capacity, as well as the key target market localized sales force strength, needed to really deliver in 2016 on its aspirations of continued profitability.

This is true whether we are talking about the $10 billion plus global glucose monitoring and diabetes management device market (Kalorama Information), or the smartphone market, which shipped around 1.44 billion units last year (IDC).

Take a closer look, visit http://www.forwardindustries.com/

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.


Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

FlexWeek, Inc. (FXWK) Eliminates Wasted Timeshare Inventory with Its Innovative and Efficient Marketplace

Owning a timeshare has many benefits. It is a great way to enjoy a relaxing vacation spot in a luxurious, fully furnished condo instead of an expensive, cookie-cutter hotel room or resort. Also, it is a much more affordable way of adding a second home, so to speak, to your book of assets. Family vacations and private getaways are essential for people to maintain their sanity by escaping to an exotic location for some much needed rest and relaxation. Of course, there is a caveat to this, and that is the money wasted should you not be able to use your allotted paid-for vacation time. Enter FlexWeek, Inc. (OTC: FXWK), a global peer-to-peer marketplace that allows timeshare owners to discover, book, and offer unused vacation time directly to the public and other timeshare owners.

This is a fantastic and well thought out addition to the timeshare dynamic, because it reduces unused timeshare inventory by utilizing the FlexWeek marketplace. The average timeshare is only booked 79 percent of the year, according to the American Resort Development Association’s 2012 research survey. Whether or not a privately owned timeshare unit is used, the owner still has to pay annual maintenance fees, and most owners end up losing thousands of dollars in wasted paid-for vacation time over their ownership period.

With FlexWeek, an owner of unused paid vacation time can now offer their specific booked week for rent directly to the FlexWeek marketplace to recoup costs or even make a profit on the rental. The glut of unused timeshare inventory allows a potential renter to stay in a very nice condo for a fraction of what they would pay in hotel fees, making it a win-win for both the owner and the renter of the vacation time.

Everyone hates fees, and, apparently, FlexWeek took this into consideration when devising its business model. The company is similar to the very popular $20 billion business model of AirBNB, but FlexWeek is the first and only peer-to-peer marketplace exclusive to fractional vacation ownerships. With FlexWeek, there is no need for costly trading platforms such as Interval International or RCI. Instead, booking fees are charged to the renter of the vacation time, eliminating the cost to the private timeshare owner.

For more information, visit www.flexweek.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.


Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

CEO Rik J. Deitsch reveals Nutra Pharma Corporation’s (NPHC) Value in Interview

In a recent interview (http://dtn.fm/j0AJN) with Stock News Now, the CEO of Nutra Pharma Corporation (OTCQB: NPHC), Rik J. Deitsch, talked about his company’s potential and the value locked in its chest of intellectual property rights. He said that, first and foremost, Nutra Pharma is a bio-technology company, with 21 patents on treatments for myasthenia gravis (MG), juvenile multiple sclerosis (MS), adrenomyeloneuropathy (AMN), human immunodeficiency virus (HIV) and pain. Being a bio-tech company is the “blood… the genetics of the company,” he enthused. As he had explained (http://dtn.fm/hy6Oj) earlier, “Instead of looking at us as a biotech with, potentially, multibillion-dollar drugs in the pipeline, analysts are seeing us as a company that sells OTC homeopathic drugs. They’re tying valuation to sales and stock performance. I think they should look at us as a speculative biotech company. In fact, we had a higher market cap before we made a penny of revenue…”

The company has three key patents: one for autoimmune disease, one for pain, and one for antiviral therapeutics. These patents protect different ways of modifying biologics including native cobra venom. (A biologic is produced in a living organism and then extracted for use. A drug is manufactured by combining substances in a chemically-ordered process.) With regard to autoimmune diseases, typically there is one drug for a particular immune disease. However, since Nutra Pharma’s RPI-78M is a modulating agent rather than an immunosuppressive one that shuts off the immune system, it could, theoretically, work against any autoimmune disease. The company has explored RPI-78M’s use in pediatric or juvenile MS, but it believes the drug can also be used against MG, rheumatoid arthritis, Hashimoto’s thyroiditis and type 1 diabetes.

Nutra Pharma has already received orphan status for RPI-78M for the treatment of juvenile (under the age of 16) MS sufferers. It believes it can really improve the lives of MS sufferers by introducing an entirely new way of treating the condition. At present, MS is treated with immunosuppressive drugs that can only slow the progression of the disease. Based on clinical studies of RPI-78M, the company expects RPI-78M may have the potential to not only stop further development of the disease but reverse its symptoms. Deitsch has speculated, “If we can get the drug through Phase I and Phase II trials, we plan to license it to a large pharma partner. We expect it to change the way we treat autoimmune diseases.”

In addition, receiving orphan status for RPI-78M brings a number of bonuses for Nutra Pharma. Not only does orphan status give the company a fast track at the FDA, it gives it the ears of the FDA and rolling review. It gives it access to grants and collaborative research agreements, and, in a relatively recent change, once a company has an approved orphaned drug, it may be able to receive an orphan drug voucher, which allows it to get a second drug approved and still have the benefits of orphan status. That second drug doesn’t have to be for an orphan condition; a company can use it for any drug. Those vouchers are salable assets. According to a report (http://dtn.fm/WCgw9) on the website of the Regulatory Affairs Professionals Society (RAPS), the first rare pediatric disease voucher was given to the pharmaceutical company BioMarin in February 2014 after its rare disease drug Vimizim was granted FDA approval. A few months later, Biomarin announced it had sold its voucher to Sanofi and Regeneron for $67.5 million. Deitsch has said (http://dtn.fm/mzX2T) that in August 2015, another voucher sold for more than $340 million.

Rik Deitsch is a biochemist. He was, at one time, head of product development for a division of Rexall Sundown, where he was involved in the launch of some 50 dietary supplements. He has worked in biochemistry for over 20 years and has written two books: Are You AgeWise: A Guide to Healthy Aging and Invisible Killers: The Truth About Environmental Genocide. From what we’ve heard in this interview, Deitsch is equally at home in the boardroom and in the lab.

For more information on the company, visit www.NutraPharma.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net